Instil Bio Statistics
Share Statistics
Instil Bio has 6.56M
shares outstanding. The number of shares has increased by 0.34%
in one year.
| Shares Outstanding | 6.56M |
| Shares Change (YoY) | 0.34% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 80.46% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,342 |
| FTD / Avg. Volume | 0.76% |
Short Selling Information
The latest short interest is 452.77K, so 6.9% of the outstanding
shares have been sold short.
| Short Interest | 452.77K |
| Short % of Shares Out | 6.9% |
| Short % of Float | 11.87% |
| Short Ratio (days to cover) | 4.7 |
Valuation Ratios
The PE ratio is -1.68 and the forward
PE ratio is -2.31.
Instil Bio's PEG ratio is
0.03.
| PE Ratio | -1.68 |
| Forward PE | -2.31 |
| PS Ratio | 0 |
| Forward PS | 20.9 |
| PB Ratio | 0.73 |
| P/FCF Ratio | -2.23 |
| PEG Ratio | 0.03 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Instil Bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.76,
with a Debt / Equity ratio of 0.51.
| Current Ratio | 15.76 |
| Quick Ratio | 15.76 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | -1.41 |
| Debt / FCF | -1.56 |
| Interest Coverage | -8.18 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-5,295,357.14 |
| Employee Count | 14 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 152.1% in the
last 52 weeks. The beta is 1.8, so Instil Bio's
price volatility has been higher than the market average.
| Beta | 1.8 |
| 52-Week Price Change | 152.1% |
| 50-Day Moving Average | 16.76 |
| 200-Day Moving Average | 25.22 |
| Relative Strength Index (RSI) | 65.08 |
| Average Volume (20 Days) | 176,203 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -73.54M |
| Net Income | -74.14M |
| EBITDA | -61.53M |
| EBIT | -66.14M |
| Earnings Per Share (EPS) | -11.39 |
Full Income StatementBalance Sheet
The company has 8.8M in cash and 86.89M in
debt, giving a net cash position of -78.08M.
| Cash & Cash Equivalents | 8.8M |
| Total Debt | 86.89M |
| Net Cash | -78.08M |
| Retained Earnings | -655.12M |
| Total Assets | 237.45M |
| Working Capital | 111.8M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -55.7M
and capital expenditures 0, giving a free cash flow of -55.7M.
| Operating Cash Flow | -55.7M |
| Capital Expenditures | n/a |
| Free Cash Flow | -55.7M |
| FCF Per Share | -8.56 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
